591
Views
0
CrossRef citations to date
0
Altmetric
Review

Management of Chronic Visceral Pain

, , , &
Pages 469-486 | Received 21 Dec 2015, Accepted 22 Apr 2016, Published online: 03 Jun 2016

References

  • Sandler RS , StewartWF , LibermanJN , RicciJA , ZorichNL . Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact . Dig. Dis. Sci.45 ( 6 ), 1166 – 1171 ( 2000 ).
  • Cervero F . Conference Proceedings, 5th World Congress on Pain: visceral pain . In : Pain Research and Clinical Management . DubnerR , GebhartGF , BondMR ( Eds ). Amsterdam, The Netherlands , 216 – 226 ( 1988 ).
  • Jänig W , HablerHJ . Visceral-autonomic integration . In : Visceral pain, Progress in Pain Research and Management . GebhartGF ( Ed. ). IASP Press , WA, USA , 311 – 348 ( 1995 ).
  • Laird JM , RozaC , CerveroF . Effects of artificial calculosis on rat ureter motility: peripheral contribution to the pain of ureteric colic . Am. J. Physiol.272 ( 5 Pt 2 ), R1409 – R1416 ( 1997 ).
  • Gebhart GF . Visceral pain – peripheral sensitisation . Gut47 ( Suppl. 4 ), iv54 – iv55 ( 2000 ).
  • Olivar T , LairdJM . Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes . Pain79 ( 1 ), 67 – 73 ( 1999 ).
  • Lelic D , OlesenSS , ValerianiM , DrewesAM . Brain source connectivity reveals the visceral pain network . Neuroimage60 ( 1 ), 37 – 46 ( 2012 ).
  • IASP Taxonomy ( 2015 ). www.iasp-pain.org/Taxonomy .
  • Gebhart GF . Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV. Visceral afferent contributions to the pathobiology of visceral pain . Am. J. Physiol. Gastrointest. Liver Physiol.278 ( 6 ), G834 – G838 ( 2000 ).
  • D’Mello R , DickensonAH . Spinal cord mechanisms of pain . Br. J. Anaesth.101 ( 1 ), 8 – 16 ( 2008 ).
  • Julius D , BasbaumAI . Molecular mechanisms of nociception . Nature413 ( 6852 ), 203 – 210 ( 2001 ).
  • Anand P , AzizQ , WillertR , van OudenhoveL . Peripheral and central mechanisms of visceral sensitization in man . Neurogastroenterol. Motil.19 ( 1 ), 29 – 46 ( 2007 ).
  • Woolf CJ , SalterMW . Neuronal plasticity: increasing the gain in pain . Science288 ( 5472 ), 1765 – 1769 ( 2000 ).
  • Al-Chaer ED , LawandNB , WestlundKN , WillisWD . Visceral nociceptive input into the ventral posterolateral nucleus of the thalamus: a new function for the dorsal column pathway . J. Neurophysiol.76 ( 4 ), 2661 – 2674 ( 1996 ).
  • Lottrup C , OlesenSS , DrewesAM . The pain system in oesophageal disorders: mechanisms, clinical characteristics, and treatment . Gastroenterol. Res. Pract.2011 , 910420 ( 2011 ).
  • Arendt-Nielsen L , LaursenRJ , DrewesAM . Referred pain as an indicator for neural plasticity . Prog. Brain Res.129 , 343 – 356 ( 2000 ).
  • Frokjaer JB , AndersenSD , GaleJ , Arendt-NielsenL , GregersenH , DrewesAM . An experimental study of viscero-visceral hyperalgesia using an ultrasound-based multimodal sensory testing approach . Pain119 ( 1–3 ), 191 – 200 ( 2005 ).
  • Olesen SS , BrockC , KrarupALet al. Descending inhibitory pain modulation is impaired in patients with chronic pancreatitis . Clin. Gastroenterol. Hepatol.8 ( 8 ), 724 – 730 ( 2010 ).
  • Brinkert W , DimcevskiG , Arendt-NielsenL , DrewesAM , Wilder-SmithOH . Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and rectum . Pain132 ( Suppl. 1 ), S46 – S51 ( 2007 ).
  • Woolf CJ . Central sensitization: implications for the diagnosis and treatment of pain . Pain152 ( 3 Suppl. ), S2 – S15 ( 2011 ).
  • Cervero F . Visceral pain – central sensitisation . Gut47 ( Suppl. 4 ), iv56 – iv57 ( 2000 ).
  • Willert RP , WoolfCJ , HobsonAR , DelaneyC , ThompsonDG , AzizQ . The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor . Gastroenterology126 ( 3 ), 683 – 692 ( 2004 ).
  • Knowles CH , AzizQ . Basic and clinical aspects of gastrointestinal pain . Pain141 ( 3 ), 191 – 209 ( 2009 ).
  • Giamberardino MA , CostantiniR , AffaitatiGet al. Viscero-visceral hyperalgesia: characterization in different clinical models . Pain151 ( 2 ), 307 – 322 ( 2010 ).
  • Giamberardino MA , BerkleyKJ , AffaitatiGet al. Influence of endometriosis on pain behaviors and muscle hyperalgesia induced by a ureteral calculosis in female rats . Pain95 ( 3 ), 247 – 257 ( 2002 ).
  • Heinricher MM , TavaresI , LeithJL , LumbBM . Descending control of nociception: specificity, recruitment and plasticity . Brain Res. Rev.60 ( 1 ), 214 – 225 ( 2009 ).
  • Fields H . State-dependent opioid control of pain . Nat. Rev. Neurosci.5 ( 7 ), 565 – 575 ( 2004 ).
  • Vanegas H , SchaibleHG . Descending control of persistent pain: inhibitory or facilitatory?Brain Res. Brain Res. Rev.46 ( 3 ), 295 – 309 ( 2004 ).
  • Gebhart GF . Descending modulation of pain . Neurosci. Biobehav. Rev.27 ( 8 ), 729 – 737 ( 2004 ).
  • Greenwood-Van Meerveld B , PrusatorDK , JohnsonAC . Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges . Am. J. Physiol. Gastrointest. Liver Physiol.308 ( 11 ), G885 – G903 ( 2015 ).
  • Price DD , StaudR , RobinsonME , MauderliAP , CannonR , VierckCJ . Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients . Pain99 ( 1–2 ), 49 – 59 ( 2002 ).
  • Price DD . Psychological and neural mechanisms of the affective dimension of pain . Science288 ( 5472 ), 1769 – 1772 ( 2000 ).
  • Shankland WE . Factors that affect pain behavior . Cranio29 ( 2 ), 144 – 154 ( 2011 ).
  • Drewes AM , GregersenH . Multimodal pain stimulation of the gastrointestinal tract . World J. Gastroenterol.12 ( 16 ), 2477 – 2486 ( 2006 ).
  • Olesen AE , AndresenT , StaahlC , DrewesAM . Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs . Pharmacol. Rev.64 ( 3 ), 722 – 779 ( 2012 ).
  • Arendt-Nielsen L , CuratoloM , DrewesA . Human experimental pain models in drug development: translational pain research . Curr. Opin. Investig Drugs8 ( 1 ), 41 – 53 ( 2007 ).
  • Olesen AE , BrockC , SverrisdottirE , LarsenIM , DrewesAM . Sensitivity of quantitative sensory models to morphine analgesia in humans . J. Pain Res.7 , 717 – 726 ( 2014 ).
  • Whitehead WE , PalssonO , JonesKR . Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?Gastroenterology122 ( 4 ), 1140 – 1156 ( 2002 ).
  • Jadad AR , BrowmanGP . The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation . JAMA274 ( 23 ), 1870 – 1873 ( 1995 ).
  • Holdgate A , PollockT . Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic . BMJ328 ( 7453 ), 1401 ( 2004 ).
  • Marjoribanks J , AyelekeRO , FarquharC , ProctorM . Nonsteroidal anti-inflammatory drugs for dysmenorrhoea . Cochrane Database Syst. Rev. ( 7 ), CD001751 ( 2015 ).
  • Allen C , HopewellS , PrenticeA , GregoryD . Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis . Cochrane Database Syst. Rev. ( 2 ), CD004753 ( 2009 ).
  • Brown J , FarquharC . Endometriosis: an overview of Cochrane Reviews . Cochrane Database Syst. Rev. ( 3 ), CD009590 ( 2014 ).
  • Nalamachu S . An overview of pain management: the clinical efficacy and value of treatment . Am. J. Manag. Care19 ( 14 Suppl. ), s261 – s266 ( 2013 ).
  • Joranson DE , RyanKM , GilsonAM , DahlJL . Trends in medical use and abuse of opioid analgesics . JAMA283 ( 13 ), 1710 – 1714 ( 2000 ).
  • Staahl C , DimcevskiG , AndersenSDet al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study . Scand. J. Gastroenterol.42 ( 3 ), 383 – 390 ( 2007 ).
  • Wilder-Smith CH , HillL , OslerW , O’KeefeS . Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis . Dig. Dis. Sci.44 ( 6 ), 1107 – 1116 ( 1999 ).
  • Lopopolo M , AffaitatiG , FabrizioAet al. Effects of tramadol on viscero-visceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis . Fundam. Clin. Pharmacol.28 ( 3 ), 331 – 341 ( 2014 ).
  • Warshaw AL , BanksPA , Fernandez-Del CastilloC . AGA technical review: treatment of pain in chronic pancreatitis . Gastroenterology115 ( 3 ), 765 – 776 ( 1998 ).
  • Delvaux M , BeckA , JacobJ , BouzamondoH , WeberFT , FrexinosJ . Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome . Aliment. Pharmacol. Ther.20 ( 2 ), 237 – 246 ( 2004 ).
  • Delvaux M , LouvelD , LagierE , ScherrerB , AbitbolJL , FrexinosJ . The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome . Gastroenterology116 ( 1 ), 38 – 45 ( 1999 ).
  • Eisenach JC , CarpenterR , CurryR . Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis . Pain101 ( 1–2 ), 89 – 95 ( 2003 ).
  • Mercadante S , TirelliW , DavidFet al. Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study . Clin. J. Pain26 ( 9 ), 794 – 797 ( 2010 ).
  • Drewes AM , JensenRD , NielsenLMet al. Differences between opioids: pharmacological, experimental, clinical and economical perspectives . Br. J. Clin. Pharmacol.75 ( 1 ), 60 – 78 ( 2013 ).
  • Kurz A , SesslerDI . Opioid-induced bowel dysfunction: pathophysiology and potential new therapies . Drugs63 ( 7 ), 649 – 671 ( 2003 ).
  • Wood JD , GalliganJJ . Function of opioids in the enteric nervous system . Neurogastroenterol. Motil.16 ( Suppl. 2 ), 17 – 28 ( 2004 ).
  • Brock C , OlesenSS , OlesenAE , FrokjaerJB , AndresenT , DrewesAM . Opioid-induced bowel dysfunction: pathophysiology and management . Drugs72 ( 14 ), 1847 – 1865 ( 2012 ).
  • Poulsen JL , OlesenSS , MalverLP , FrokjaerJB , DrewesAM . Pain and chronic pancreatitis: a complex interplay of multiple mechanisms . World J. Gastroenterol.19 ( 42 ), 7282 – 7291 ( 2013 ).
  • Poulsen JL , BrockC , OlesenAE , NilssonM , DrewesAM . Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction . Clin. Exp. Gastroenterol.7 , 345 – 358 ( 2014 ).
  • Drossman D , SzigethyE . The narcotic bowel syndrome: a recent update . Am. J. Gastroenterol.2 ( 1 ), 22 – 30 ( 2014 ).
  • Farmer AD , FerdinandE , AzizQ . Opioids and the gastrointestinal tract – a case of narcotic bowel syndrome and literature review . J. Neurogastroenterol Motil.19 ( 1 ), 94 – 98 ( 2013 ).
  • Bouwense SA , de VriesM , SchreuderLTet al. Systematic mechanism-orientated approach to chronic pancreatitis pain . World J. Gastroenterol.21 ( 1 ), 47 – 59 ( 2015 ).
  • Chen L , MaoJ . Update on neuropathic pain treatment: ion channel blockers and gabapentinoids . Curr. Pain Headache Rep. doi: 10.1007/s11916-013-0359-2 ( 2013 ) ( Epub ahead of print ).
  • Lee KJ , KimJH , ChoSW . Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome . Aliment. Pharmacol. Ther.22 ( 10 ), 981 – 988 ( 2005 ).
  • Houghton LA , FellC , WhorwellPJ , JonesI , SudworthDP , GaleJD . Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome . Gut56 ( 9 ), 1218 – 1225 ( 2007 ).
  • Olesen SS , GraversenC , BouwenseSA , van GoorH , Wilder-SmithOH , DrewesAM . Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis . PLoS ONE8 ( 3 ), e57963 ( 2013 ).
  • Olesen SS , BouwenseSA , Wilder-SmithOH , van GoorH , DrewesAM . Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial . Gastroenterology141 ( 2 ), 536 – 543 ( 2011 ).
  • Tornblom H , DrossmanDA . Centrally targeted pharmacotherapy for chronic abdominal pain . Neurogastroenterol. Motil.27 ( 4 ), 455 – 467 ( 2015 ).
  • Ford AC , QuigleyEM , LacyBEet al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis . Am. J. Gastroenterol.109 ( 9 ), 1350 – 1365 ; quiz 1366 ( 2014 ).
  • Srinath A , YoungE , SzigethyE . Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside . Inflamm. Bowel Dis.20 ( 12 ), 2433 – 2449 ( 2014 ).
  • Bell RF . Ketamine for chronic non-cancer pain . Pain141 ( 3 ), 210 – 214 ( 2009 ).
  • Bouwense SA , BuscherHC , van GoorH , Wilder-SmithOH . S-ketamine modulates hyperalgesia in patients with chronic pancreatitis pain . Reg. Anesth. Pain Med.36 ( 3 ), 303 – 307 ( 2011 ).
  • Juel J , OlesenSS , OlesenAEet al. Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial) . BMJ Open5 ( 3 ), e007087 ( 2015 ).
  • Bannwarth B , KostineM . Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists?Drugs74 ( 6 ), 619 – 626 ( 2014 ).
  • Evans RJ , MoldwinRM , CossonsN , DarekarA , MillsIW , ScholfieldD . Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis . J. Urol.185 ( 5 ), 1716 – 1721 ( 2011 ).
  • Zhu Y , ColakT , ShenoyMet al. Nerve growth factor modulates TRPV1 expression and function and mediates pain in chronic pancreatitis . Gastroenterology141 ( 1 ), 370 – 377 ( 2011 ).
  • Lee Y , HongS , CuiM , SharmaPK , LeeJ , ChoiS . Transient receptor potential vanilloid type 1 antagonists: a patent review (2011–2014) . Expert Opin. Ther. Pat.25 ( 3 ), 291 – 318 ( 2015 ).
  • Lapointe TK , BassoL , IftincaMCet al. TRPV1 sensitization mediates postinflammatory visceral pain following acute colitis . Am. J. Physiol. Gastrointest. Liver Physiol.309 ( 2 ), G87 – G99 ( 2015 ).
  • Altomare A , GuarinoMP , EmerenzianiSet al. Gastrointestinal sensitivity and gastroesophageal reflux disease . Ann. NY Acad. Sci.1300 , 80 – 95 ( 2013 ).
  • Akbar A , YiangouY , FacerP , WaltersJR , AnandP , GhoshS . Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain . Gut57 ( 7 ), 923 – 929 ( 2008 ).
  • Chey WD , LemboAJ , LavinsBJet al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety . Am. J. Gastroenterol.107 ( 11 ), 1702 – 1712 ( 2012 ).
  • Busby RW , BryantAP , BartoliniWPet al. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit . Eur. J. Pharmacol.649 ( 1–3 ), 328 – 335 ( 2010 ).
  • Castro J , HarringtonAM , HughesPAet al. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3′,5′-monophosphate . Gastroenterology145 ( 6 ), 1334 – 1346.e1–11 ( 2013 ).
  • Dumitrascu DL , ChiraA , BatagaSet al. The use of mebeverine in irritable bowel syndrome. A Position paper of the Romanian Society of Neurogastroenterology based on evidence . J. Gastrointestin Liver Dis.23 ( 4 ), 431 – 435 ( 2014 ).
  • Dunphy RC , VerneGN . Drug treatment options for irritable bowel syndrome: managing for success . Drugs Aging18 ( 3 ), 201 – 211 ( 2001 ).
  • Malik Z , BaikD , ScheyR . The role of cannabinoids in regulation of nausea and vomiting, and visceral pain . Curr. Gastroenterol. Rep. doi:10.1007/s11894-015-0429-1 ( 2015 ) ( Epub ahead of print ).
  • Ruffle JK , BajgoricS , SamraK , ChandrapalanS , AzizQ , FarmerAD . Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting . Eur. J. Gastroenterol. Hepatol.27 ( 12 ), 1403 – 1408 ( 2015 ).
  • Vickers AJ , CroninAM , MaschinoACet al. Acupuncture for chronic pain: individual patient data meta-analysis . Arch. Intern. Med.172 ( 19 ), 1444 – 1453 ( 2012 ).
  • Witt C , BrinkhausB , JenaSet al. Acupuncture in patients with osteoarthritis of the knee: a randomised trial . Lancet366 ( 9480 ), 136 – 143 ( 2005 ).
  • Ng SS , LeungWW , MakTWet al. Electroacupuncture reduces duration of postoperative ileus after laparoscopic surgery for colorectal cancer . Gastroenterology144 ( 2 ), 307 – 313.e1 ( 2013 ).
  • Kaptchuk TJ , KelleyJM , ConboyLAet al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome . BMJ336 ( 7651 ), 999 – 1003 ( 2008 ).
  • Juel J , LiguoriS , LiguoriAet al. A new method for sham-controlled acupuncture in experimental visceral pain – a randomized, single-blinded study . Pain Pract. doi:10.1111/papr.12309 ( 2015 ) ( Epub ahead of print ).
  • Moisset X , de AndradeDC , BouhassiraD . From pulses to pain relief: an update on the mechanisms of rTMS-induced analgesic effects . Eur. J. Pain doi:10.1002/ejp.811 ( 2015 ) ( Epub ahead of print ).
  • Melchior C , GourcerolG , ChastanNet al. Effect of transcranial magnetic stimulation on rectal sensitivity in irritable bowel syndrome: a randomized, placebo-controlled pilot study . Colorectal Dis.16 ( 3 ), O104 – O111 ( 2014 ).
  • Algladi T , HarrisM , WhorwellPJ , PaineP , HamdyS . Modulation of human visceral sensitivity by noninvasive magnetoelectrical neural stimulation in health and irritable bowel syndrome . Pain156 ( 7 ), 1348 – 1356 ( 2015 ).
  • Fregni F , PotvinK , DasilvaDet al. Clinical effects and brain metabolic correlates in non-invasive cortical neuromodulation for visceral pain . Eur. J. Pain15 ( 1 ), 53 – 60 ( 2011 ).
  • Napadow V , EdwardsRR , CahalanCMet al. Evoked pain analgesia in chronic pelvic pain patients using respiratory-gated auricular vagal afferent nerve stimulation . Pain Med.13 ( 6 ), 777 – 789 ( 2012 ).
  • Fr⊘kjær JB , BergmannS , BrockCet al. Modulation of vagal tone enhances gastro-duodenal motility and reduces somatic pain sensitivity . Neurogastroenterol. Motil. ( 2015 ) ( In Press ).
  • Palsson OS , DrossmanDA . Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments . Gastroenterol. Clin. North Am.34 ( 2 ), 281 – 303 ( 2005 ).
  • Zijdenbos IL , de WitNJ , van der HeijdenGJ , RubinG , QuarteroAO . Psychological treatments for the management of irritable bowel syndrome . Cochrane Database Syst. Rev. ( 1 ), CD006442 ( 2009 ).
  • Lackner JM , JaccardJ , KrasnerSS , KatzLA , GudleskiGD , HolroydK . Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility . Clin. Gastroenterol. Hepatol.6 ( 8 ), 899 – 906 ( 2008 ).
  • Mathew P , BhatiaSJ . Pathogenesis and management of irritable bowel syndrome . Trop. Gastroenterol.30 ( 1 ), 19 – 25 ( 2009 ).
  • Altayar O , SharmaV , ProkopLJ , SoodA , MuradMH . Psychological therapies in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials . Gastroenterol. Res. Pract.2015 , 549308 ( 2015 ).
  • Miller V , WhorwellPJ . Hypnotherapy for functional gastrointestinal disorders: a review . Int. J. Clin. Exp. Hypn.57 ( 3 ), 279 – 292 ( 2009 ).
  • Miller V , CarruthersHR , MorrisJ , HasanSS , ArchboldS , WhorwellPJ . Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients . Aliment. Pharmacol. Ther.41 ( 9 ), 844 – 855 ( 2015 ).
  • Houghton LA , HeymanDJ , WhorwellPJ . Symptomatology, quality of life and economic features of irritable bowel syndrome – the effect of hypnotherapy . Aliment. Pharmacol. Ther.10 ( 1 ), 91 – 95 ( 1996 ).
  • Prior A , ColganSM , WhorwellPJ . Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome . Gut31 ( 8 ), 896 – 898 ( 1990 ).
  • Webb AN , KukuruzovicRH , Catto-SmithAG , SawyerSM . Hypnotherapy for treatment of irritable bowel syndrome . Cochrane Database Syst. Rev. ( 4 ), CD005110 ( 2007 ).
  • Whorwell PJ , PriorA , FaragherEB . Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome . Lancet2 ( 8414 ), 1232 – 1234 ( 1984 ).
  • Wilson S , MaddisonT , RobertsL , GreenfieldS , SinghS . Birmingham IBS Research Group. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome . Aliment. Pharmacol. Ther.24 ( 5 ), 769 – 780 ( 2006 ).
  • Lovdahl J , RingstromG , AgerforzP , TornblomH , SimrenM . Nurse-administered, gut-directed hypnotherapy in IBS: efficacy and factors predicting a positive response . Am. J. Clin. Hypn.58 ( 1 ), 100 – 114 ( 2015 ).
  • Keohane J , O’MahonyC , O’MahonyL , O’MahonyS , QuigleyEM , ShanahanF . Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?Am. J. Gastroenterol.105 ( 8 ), 1788 , 1789–1794; quiz 1795 ( 2010 ).
  • Gilron I , BaileyJM , TuD , HoldenRR , WeaverDF , HouldenRL . Morphine, gabapentin, or their combination for neuropathic pain . N. Engl. J. Med.352 ( 13 ), 1324 – 1334 ( 2005 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.